[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@fabitrades "Good morning ☀ Small Cap gainers pre-market: $BYND +76% $REPL +61% $FGI +42% $RANI +23% $SINT +23% $DGXX +22% $NUAI +19% $DVLT +14% $STKE +10% $SLS +8%"
X Link @fabitrades 2025-10-20T11:12Z 1480 followers, XXX engagements

"Small Cap Gainers Pre-Market reAlpha Tech Corp. - $AIRE - Sector: Real Estate - Services Market Cap: 65.77M Float: 24.26M News: Capital raise and AI platform integration fuel pre-market surge. The issuance of over XX million shares raised approximately $XXX million aimed at expanding operations including the integration of Naamche into the company's AI-driven real estate platform which has generated positive momentum among investors despite initial concerns over dilution leading to a rebound and significant price increase following the announcement earlier this week. - FinViz AI"
X Link @fabitrades 2025-10-22T11:34Z 1481 followers, XXX engagements

"Small Cap Gainers Pre-Market Telomir Pharmaceuticals Inc. - $TELO - Sector: Healthcare - Biotechnology Market Cap: 44.55M Float: 14.48M News: Telomir Pharmaceuticals reports new preclinical data showing oral Telomir-1 resets DNA methylation in CASP8 (apoptosis "kill" pathway) and GSTP1 (glutathione detoxification "clean" pathway) in aggressive prostate cancer mouse model reactivating defenses disrupted in cancer. Outperformed Rapamycin (transient effects) and chemo (no methylation reduction alone); combo with chemo enhanced benefits. CSA Dr. Itzchak Angel: Highlights epigenetic modulation vs."
X Link @fabitrades 2025-10-23T11:35Z 1481 followers, XXX engagements

"Small Cap Gainers Pre-Market Scienture Holdings Inc. - $SCNX - Sector: Healthcare - Pharmaceutical Retailers Market Cap: 13.28M Float: 16.94M News: Scienture Holdings launches commercial sales and fulfills initial orders for Arbli (losartan potassium) Oral Suspension XX mg/mLthe first FDA-approved ready-to-use liquid formulation for hypertension stroke risk reduction and diabetic nephropathy in patients X years old. Targets $256M US losartan market with 71M annual prescriptions offering consistent dosing without compounding. Multi-channel HCP outreach underway with PBM-led GPO and multiple"
X Link @fabitrades 2025-10-23T12:19Z 1481 followers, XXX engagements

"Small Cap Gainers Pre-Market IM Cannabis Corp. - $IMCC - Sector: Healthcare - Drug Manufacturers Market Cap: 9.76M Float: 1.71M News: IM Cannabis signs non-binding term sheet to acquire XX% stake in a quantum computing bio data companyspecializing in efficient storage/manipulation/analysis of biological datafor up to $54M in cash shares and performance-tied earn-outs. Deal supports diversification for long-term growth/shareholder value pending due diligence definitive agreements and approvals"
X Link @fabitrades 2025-10-23T13:19Z 1481 followers, XXX engagements

"Good morning Small Cap gainers pre-market: $GNTA +278% $WGRX +110% $QLGN +69% $NEUP +45% $AIIO +12% $VIOT +10%"
X Link @fabitrades 2025-10-24T11:30Z 1479 followers, XXX engagements

"Small Cap Gainers Pre-Market Rani Therapeutics Holdings Inc. - $RANI - Sector: Healthcare - Biotechnology Market Cap: 33.84M Float: 35.99M News: Rani Therapeutics announced a collaboration with Chugai Pharmaceutical to develop an oral rare disease antibody using RaniPill technology with a $XX million upfront payment up to $XX million in development milestones $XXX million in sales milestones and royalties. Chugai can extend the deal to five more targets potentially totaling $XXXXX billion. Rani also secured a $XXXX million private placement extending its cash runway into 2028"
X Link @fabitrades 2025-10-17T11:33Z 1478 followers, XXX engagements

"Small Cap Gainers Pre-Market Replimune Group Inc. - $REPL - Sector: Healthcare - Biotechnology Market Cap: 351.25M Float: 66.34M News: Replimune Group Inc. announced that the FDA has accepted the resubmission of the Biologics License Application (BLA) for RP1 combined with nivolumab to treat advanced melanoma in patients who progressed on anti-PD-1 therapy. The FDA set a PDUFA target action date of April XX 2026. RP1 Replimunes lead candidate is an oncolytic immunotherapy designed to enhance tumor-killing and stimulate systemic anti-tumor immune responses"
X Link @fabitrades 2025-10-20T11:23Z 1478 followers, XXX engagements

"Small Cap Gainers Pre-Market 1-800 Flowers-com Inc. - $FLWS - Sector: Consumer Cyclical -Specialty Retail Market Cap: 327.64M Float: 31.19M News: No recent news"
X Link @fabitrades 2025-10-22T13:19Z 1478 followers, XXX engagements

"Small Caps on watch for market open: $AIRE $BNBX $FLWS $AREB $SBEV $RANI GLHF 🍀"
X Link @fabitrades 2025-10-22T13:30Z 1478 followers, XXX engagements

"Small Caps on watch for market open: $VTYX $SCNX $SLMT $SGBX $RBNE $IBIO $AREB $TPET $ELBM $NUAI $IMCC Wish you a successful trading session 🍀"
X Link @fabitrades 2025-10-23T13:20Z 1478 followers, XXX engagements

"Small Cap Gainers Pre-Market Genenta Science SpA - $GNTA - Sector: Healthcare - Biotechnology Market Cap: 61.85M Float: - / 19.15M Shares Outstanding News: Genenta Science and Anemocyte announce expanded strategic partnership to advance off-the-shelf lentiviral vector (LVV) Plasmid DNA production leveraging Genenta's clinically validated platform from co-founder Prof. Luigi Naldini to provide scalable high-quality materials from R&D to GMP/commercial stages. Building on prior plasmid DNA collaboration it enhances Anemocyte's offerings for advanced therapies. CEO Pierluigi Paracchi: Natural"
X Link @fabitrades 2025-10-24T11:38Z 1479 followers, XXX engagements

"Small Cap Gainers Pre-Market Adverum Biotechnologies Inc. - $ADVM - Sector: Healthcare - Biotechnology Market Cap: 87.71M Float: 13.85M News: Eli Lilly to acquire Adverum Biotechnologies for its Phase X intravitreal gene therapy Ixo-vec a one-time treatment for wet AMD to reduce chronic anti-VEGF injection burden via tender offer of $3.56/share cash + CVR up to $XXXX (FDA approval milestone $1.78; $1B sales $7.13) totaling potential $12.47/share; deal expected Q4 2025 close with $65M bridge loan to Adverum for trials. Aligns Lilly's genetic medicines with age-related vision loss; Adverum CEO"
X Link @fabitrades 2025-10-24T13:00Z 1478 followers, XXX engagements

"Small Caps on watch for market open: $GNTA $WGRX $QLGN $NEUP $VIOT $AIIO $NUAI $PRZO GLHF 🍀"
X Link @fabitrades 2025-10-24T13:14Z 1478 followers, XXX engagements

"Week's Top X Small Cap Gainers: 🟢 $BYND +238.44% 🟢 $SCNX +193.40% 🟢 $WGRX +139.58% 🟢 $REPL +95.56% 🟢 $GNTA +95.16% How's your week been"
X Link @fabitrades 2025-10-24T21:54Z 1478 followers, XXX engagements